Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pozen sells Treximet royalty rights for $75M
Pozen sells Treximet royalty rights for $75M
Pozen sells Treximet royalty rights for $75M
Submitted by
admin
on November 28, 2011 - 11:39am
Source:
Yahoo/AP
News Tags:
Pozen
Treximet
Headline:
Pozen sells Treximet royalty rights for $75M
Do Not Allow Advertisers to Use My Personal information
